The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IRX-2 therapy with PD-L1 blockade in immunocompetent animal model.
 
Lu Wen
No Relationships to Disclose
 
Gregory T. Wolf
No Relationships to Disclose
 
Monil Shah
Employment - Brooklyn ImmunoTherapeutics; IRX Therapeutics
 
David B. Page
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NanoString Technologies; NanoString Technologies; Nektar; Puma Biotechnology; Puma Biotechnology; Syndax
Speakers' Bureau - Genentech/Roche
Research Funding - Bristol-Myers Squibb; MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune
 
Lynn Sadowski-Mason
Employment - Brooklyn ImmunoTherapeutics; IRX Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Mark Prince
No Relationships to Disclose
 
Jeffrey Moyer
Research Funding - Brooklyn ImmunoTherapeutics; IRX Therapeutics
 
Alfred E. Chang
No Relationships to Disclose
 
Qiao Li
Research Funding - Brooklyn ImmunoTherapeutics